PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"33087150","Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial","Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.","J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9.","Perrone F","J Transl Med","2020","2020/10/22","PMC7576974","","10.1186/s12967-020-02573-9"
"33087047","The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial","Gharebaghi N, Nejadrahim R, Mousavi SJ, Sadat-Ebrahimi SR, Hajizadeh R.","BMC Infect Dis. 2020 Oct 21;20(1):786. doi: 10.1186/s12879-020-05507-4.","Gharebaghi N","BMC Infect Dis","2020","2020/10/22","PMC7576972","","10.1186/s12879-020-05507-4"
"33053024","COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial","Tomazini BM, Maia IS, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Cavalcanti AB, Rosa RG, Avezum Á, Veiga VC, Lopes RD, Damiani LP, Machado FR, Berwanger O, Azevedo LCP; em nome dos investigadores da COALIZÃO COVID-19 BRASIL III.","Rev Bras Ter Intensiva. 2020 Jul-Sep;32(3):354-362. doi: 10.5935/0103-507X.20200063.","Tomazini BM","Rev Bras Ter Intensiva","2020","2020/10/14","","","10.5935/0103-507X.20200063"
"32988954","Contamination and washing of cloth masks and risk of infection among hospital health workers in Vietnam: a post hoc analysis of a randomised controlled trial","MacIntyre CR, Dung TC, Chughtai AA, Seale H, Rahman B.","BMJ Open. 2020 Sep 28;10(9):e042045. doi: 10.1136/bmjopen-2020-042045.","MacIntyre CR","BMJ Open","2020","2020/09/29","PMC7523194","","10.1136/bmjopen-2020-042045"
"32965395","Rationale and design of the ""Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled"" trial (TOCIBRAS)","Farias DLC, Prats J, Cavalcanti AB, Rosa RG, Machado FR, Berwanger O, Azevedo LCP, Lopes RD, Avezum Á, Kawano-Dourado L, Damiani LP, Rojas SSO, Oliveira CZ, Andrade LEC, Sandes AF, Pintão MC, Castro Júnior CG, Scheinberg P, Veiga VC.","Rev Bras Ter Intensiva. 2020 Jul-Sep;32(3):337-347. doi: 10.5935/0103-507X.20200060.","Farias DLC","Rev Bras Ter Intensiva","2020","2020/09/23","","","10.5935/0103-507X.20200060"
"32958495","Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults","Ader F; Discovery French Trial Management Team.","BMJ Open. 2020 Sep 21;10(9):e041437. doi: 10.1136/bmjopen-2020-041437.","Ader F","BMJ Open","2020","2020/09/22","PMC7507250","","10.1136/bmjopen-2020-041437"
"32941801","Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly","Giamarellos-Bourboulis EJ, Tsilika M, Moorlag S, Antonakos N, Kotsaki A, Domínguez-Andrés J, Kyriazopoulou E, Gkavogianni T, Adami ME, Damoraki G, Koufargyris P, Karageorgos A, Bolanou A, Koenen H, van Crevel R, Droggiti DI, Renieris G, Papadopoulos A, Netea MG.","Cell. 2020 Oct 15;183(2):315-323.e9. doi: 10.1016/j.cell.2020.08.051. Epub 2020 Sep 1.","Giamarellos-Bourboulis EJ","Cell","2020","2020/09/17","PMC7462457","","10.1016/j.cell.2020.08.051"
"32910735","Validation of a Novel Wearable Electromyography Patch for Monitoring Submental Muscle Activity During Swallowing: A Randomized Crossover Trial","Kantarcigil C, Kim MK, Chang T, Craig BA, Smith A, Lee CH, Malandraki GA.","J Speech Lang Hear Res. 2020 Oct 16;63(10):3293-3310. doi: 10.1044/2020_JSLHR-20-00171. Epub 2020 Sep 10.","Kantarcigil C","J Speech Lang Hear Res","2020","2020/09/10","","","10.1044/2020_JSLHR-20-00171"
"32896292","Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial","Furtado RHM, Berwanger O, Fonseca HA, Corrêa TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB; COALITION COVID-19 Brazil II Investigators.","Lancet. 2020 Oct 3;396(10256):959-967. doi: 10.1016/S0140-6736(20)31862-6. Epub 2020 Sep 5.","Furtado RHM","Lancet","2020","2020/09/08","","","10.1016/S0140-6736(20)31862-6"
"32895056","Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial","Kharma N, Roehrig S, Shible AA, Elshafei MS, Osman D, Elsaid IM, Mustafa SF, Aldabi A, Smain OAM, Lance MD.","Trials. 2020 Sep 7;21(1):769. doi: 10.1186/s13063-020-04689-1.","Kharma N","Trials","2020","2020/09/08","PMC7476433","","10.1186/s13063-020-04689-1"
"32892275","Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study","Li J, Bao L, Xia Z, Wang S, Zhou X, Ding K, Zhang W, Yang W, Li B, Fu C, Chen B, Hua L, Wang L, Luo J, Yang Y, Xu T, Wang W, Huang Y, Wu G, Liu P.","Ann Hematol. 2020 Nov;99(11):2589-2598. doi: 10.1007/s00277-020-04234-9. Epub 2020 Sep 6.","Li J","Ann Hematol","2020","2020/09/06","PMC7474576","","10.1007/s00277-020-04234-9"
"32867852","Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial","Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, John O, Ghosh A, Bassi A, Arfin S, Kunigari M, Joshi R, Donaldson L, Hammond N, Venkatesh B; HOPE investigators.","Trials. 2020 Aug 31;21(1):754. doi: 10.1186/s13063-020-04679-3.","Tirupakuzhi Vijayaraghavan BK","Trials","2020","2020/09/02","PMC7456761","","10.1186/s13063-020-04679-3"
"32855385","Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial","Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T, Huang L, Zhao P, Yuan X, Fan X, Zhang JY, Song J, Zhang D, Jiao Y, Liu L, Zhou C, Maeurer M, Zumla A, Shi M, Wang FS.","Signal Transduct Target Ther. 2020 Aug 27;5(1):172. doi: 10.1038/s41392-020-00286-5.","Meng F","Signal Transduct Target Ther","2020","2020/08/29","PMC7450163","","10.1038/s41392-020-00286-5"
"32854761","Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial","Zhang S, Zhu Q, Zhan C, Cheng W, Mingfang X, Fang M, Fang L.","Trials. 2020 Aug 27;21(1):751. doi: 10.1186/s13063-020-04693-5.","Zhang S","Trials","2020","2020/08/29","PMC7450683","","10.1186/s13063-020-04693-5"
"32854751","Hydroxychloroquine for post-exposure prophylaxis of COVID-19 among naval personnel in Sri Lanka: study protocol for a randomized, controlled trial","Niriella MA, Ediriweera DS, De Silva AP, Premarathne R, Balasooriya P, Duminda KD, Malavige NG, Wanigasuriya K, Lekamwasam S, Kularathne SA, Siribaddana S, de Silva HJ, Jayasinghe S.","Trials. 2020 Aug 27;21(1):748. doi: 10.1186/s13063-020-04659-7.","Niriella MA","Trials","2020","2020/08/29","PMC7450681","","10.1186/s13063-020-04659-7"
"32853672","Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial","Sekhavati E, Jafari F, SeyedAlinaghi S, Jamalimoghadamsiahkali S, Sadr S, Tabarestani M, Pirhayati M, Zendehdel A, Manafi N, Hajiabdolbaghi M, Ahmadinejad Z, Kouchak HE, Jafari S, Khalili H, Salehi M, Seifi A, Golestan FS, Ghiasvand F.","Int J Antimicrob Agents. 2020 Oct;56(4):106143. doi: 10.1016/j.ijantimicag.2020.106143. Epub 2020 Aug 25.","Sekhavati E","Int J Antimicrob Agents","2020","2020/08/28","PMC7445147","","10.1016/j.ijantimicag.2020.106143"
"32847626","The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial","Johansson PI, Bestle M, Søe-Jensen P, Kristiansen KT, Stensballe J, Clausen NE, Perner A.","Trials. 2020 Aug 26;21(1):746. doi: 10.1186/s13063-020-04696-2.","Johansson PI","Trials","2020","2020/08/28","PMC7447606","","10.1186/s13063-020-04696-2"
"32843098","High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial","Maskin LP, Olarte GL, Palizas F Jr, Velo AE, Lurbet MF, Bonelli I, Baredes ND, Rodríguez PO.","Trials. 2020 Aug 26;21(1):743. doi: 10.1186/s13063-020-04646-y.","Maskin LP","Trials","2020","2020/08/27","PMC7447582","","10.1186/s13063-020-04646-y"
"32831151","Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trial","Wang ZY, Fu SZ, Xu L, Li SS, Qian KJ, He XD, Zhu GC, Li LH, Zhang J, Li WF, Qin BY, Zhou CL, Ma PL.","Trials. 2020 Aug 24;21(1):738. doi: 10.1186/s13063-020-04677-5.","Wang ZY","Trials","2020","2020/08/25","PMC7443851","","10.1186/s13063-020-04677-5"
"32829745","Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19","Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, Mariager AF, Schytte N, von Buchwald C, Todsen T, Skovgaard K, Trebbien R, Andersen MP, Benfield T, Ullum H, Torp-Pedersen C, Iversen K.","Dan Med J. 2020 Aug 18;67(9):A05200363.","Bundgaard H","Dan Med J","2020","2020/08/25","","",""
"32821939","Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial","Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators.","JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.","Spinner CD","JAMA","2020","2020/08/22","PMC7442954","","10.1001/jama.2020.16349"
"32815416","Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial","Houston BL, Lawler PR, Goligher EC, Farkouh ME, Bradbury C, Carrier M, Dzavik V, Fergusson DA, Fowler RA, Galanaud JP, Gross PL, McDonald EG, Husain M, Kahn SR, Kumar A, Marshall J, Murthy S, Slutsky AS, Turgeon AF, Berry SM, Rosenson RS, Escobedo J, Nicolau JC, Bond L, Kirwan BA, de Brouwer S, Zarychanski R.","Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.","Houston BL","Clin Trials","2020","2020/08/21","","","10.1177/1740774520943846"
"32812039","Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial","Sadeghi A, Ali Asgari A, Norouzi A, Kheiri Z, Anushirvani A, Montazeri M, Hosamirudsai H, Afhami S, Akbarpour E, Aliannejad R, Radmard AR, Davarpanah AH, Levi J, Wentzel H, Qavi A, Garratt A, Simmons B, Hill A, Merat S.","J Antimicrob Chemother. 2020 Nov 1;75(11):3379-3385. doi: 10.1093/jac/dkaa334.","Sadeghi A","J Antimicrob Chemother","2020","2020/08/20","PMC7454592","","10.1093/jac/dkaa334"
"32812025","Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial","Abbaspour Kasgari H, Moradi S, Shabani AM, Babamahmoodi F, Davoudi Badabi AR, Davoudi L, Alikhani A, Hedayatizadeh Omran A, Saeedi M, Merat S, Wentzel H, Garratt A, Levi J, Simmons B, Hill A, Tirgar Fakheri H.","J Antimicrob Chemother. 2020 Nov 1;75(11):3373-3378. doi: 10.1093/jac/dkaa332.","Abbaspour Kasgari H","J Antimicrob Chemother","2020","2020/08/20","PMC7454669","","10.1093/jac/dkaa332"
"32811627","Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform","Mahoney MC, Ashare R, Schlienz N, Duerr C, Hawk LW.","J Subst Abuse Treat. 2020 Oct;117:108100. doi: 10.1016/j.jsat.2020.108100. Epub 2020 Aug 5.","Mahoney MC","J Subst Abuse Treat","2020","2020/08/20","PMC7403863","","10.1016/j.jsat.2020.108100"
"32807209","A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial","Hinks TSC, Barber VS, Black J, Dutton SJ, Jabeen M, Melhorn J, Rahman NM, Richards D, Lasserson D, Pavord ID, Bafadhel M.","Trials. 2020 Aug 17;21(1):718. doi: 10.1186/s13063-020-04593-8.","Hinks TSC","Trials","2020","2020/08/19","PMC7429453","","10.1186/s13063-020-04593-8"
"32798922","Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial","Burdick H, Lam C, Mataraso S, Siefkas A, Braden G, Dellinger RP, McCoy A, Vincent JL, Green-Saxena A, Barnes G, Hoffman J, Calvert J, Pellegrini E, Das R.","Comput Biol Med. 2020 Sep;124:103949. doi: 10.1016/j.compbiomed.2020.103949. Epub 2020 Aug 6.","Burdick H","Comput Biol Med","2020","2020/08/18","PMC7410013","","10.1016/j.compbiomed.2020.103949"
"32795330","Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial","Miller J, Bruen C, Schnaus M, Zhang J, Ali S, Lind A, Stoecker Z, Stauderman K, Hebbar S.","Crit Care. 2020 Aug 14;24(1):502. doi: 10.1186/s13054-020-03220-x.","Miller J","Crit Care","2020","2020/08/16","PMC7427272","","10.1186/s13054-020-03220-x"
"32771034","Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial","Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA.","Trials. 2020 Aug 8;21(1):703. doi: 10.1186/s13063-020-04647-x.","Koshak AE","Trials","2020","2020/08/11","PMC7414256","","10.1186/s13063-020-04647-x"
"32771032","Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial","Akram J, Azhar S, Shahzad M, Latif W, Khan KS.","Trials. 2020 Aug 8;21(1):702. doi: 10.1186/s13063-020-04616-4.","Akram J","Trials","2020","2020/08/11","PMC7414257","","10.1186/s13063-020-04616-4"
"32763640","Implementing an intensive care unit (ICU) diary program at a large academic medical center: Results from a randomized control trial evaluating psychological morbidity associated with critical illness","Sayde GE, Stefanescu A, Conrad E, Nielsen N, Hammer R.","Gen Hosp Psychiatry. 2020 Sep-Oct;66:96-102. doi: 10.1016/j.genhosppsych.2020.06.017. Epub 2020 Jul 2.","Sayde GE","Gen Hosp Psychiatry","2020","2020/08/09","PMC7329691","","10.1016/j.genhosppsych.2020.06.017"
"32758689","SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial","Zheng F, Zhou Y, Zhou Z, Ye F, Huang B, Huang Y, Ma J, Zuo Q, Tan X, Xie J, Niu P, Wang W, Xu Y, Peng F, Zhou N, Cai C, Tang W, Xiao X, Li Y, Zhou Z, Jiang Y, Xie Y, Tan W, Gong G.","Int J Infect Dis. 2020 Oct;99:84-91. doi: 10.1016/j.ijid.2020.07.053. Epub 2020 Aug 3.","Zheng F","Int J Infect Dis","2020","2020/08/08","PMC7397938","","10.1016/j.ijid.2020.07.053"
"32758298","A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial","Rodríguez-Rubio M, Figueira JC, Acuña-Castroviejo D, Borobia AM, Escames G, de la Oliva P.","Trials. 2020 Aug 5;21(1):699. doi: 10.1186/s13063-020-04632-4.","Rodríguez-Rubio M","Trials","2020","2020/08/08","PMC7403786","","10.1186/s13063-020-04632-4"
"32747329","Effect of an E-Learning Module on Personal Protective Equipment Proficiency Among Prehospital Personnel: Web-Based Randomized Controlled Trial","Suppan L, Abbas M, Stuby L, Cottet P, Larribau R, Golay E, Iten A, Harbarth S, Gartner B, Suppan M.","J Med Internet Res. 2020 Aug 21;22(8):e21265. doi: 10.2196/21265.","Suppan L","J Med Internet Res","2020","2020/08/05","PMC7446759","","10.2196/21265"
"32736596","ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial","Wilkinson T, Dixon R, Page C, Carroll M, Griffiths G, Ho LP, De Soyza A, Felton T, Lewis KE, Phekoo K, Chalmers JD, Gordon A, McGarvey L, Doherty J, Read RC, Shankar-Hari M, Martinez-Alier N, O'Kelly M, Duncan G, Walles R, Sykes J, Summers C, Singh D; ACCORD Collaborators.","Trials. 2020 Jul 31;21(1):691. doi: 10.1186/s13063-020-04584-9.","Wilkinson T","Trials","2020","2020/08/02","PMC7393340","","10.1186/s13063-020-04584-9"
"32736592","muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial","Lu IN, Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Kadyan S, Bond S, Norton S, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB, Cheriyan J.","Trials. 2020 Jul 31;21(1):690. doi: 10.1186/s13063-020-04618-2.","Lu IN","Trials","2020","2020/08/02","PMC7393245","","10.1186/s13063-020-04618-2"
"32702299","Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W.","Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20.","Zhu FC","Lancet","2020","2020/07/24","","","10.1016/S0140-6736(20)31605-6"
"32702298","Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial","Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group.","Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.","Folegatti PM","Lancet","2020","2020/07/24","PMC7445431","","10.1016/S0140-6736(20)31604-4"
"32699167","Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial","Wong CK, Ho DTY, Tam AR, Zhou M, Lau YM, Tang MOY, Tong RCF, Rajput KS, Chen G, Chan SC, Siu CW, Hung IFN.","BMJ Open. 2020 Jul 22;10(7):e038555. doi: 10.1136/bmjopen-2020-038555.","Wong CK","BMJ Open","2020","2020/07/24","PMC7380847","","10.1136/bmjopen-2020-038555"
"32676976","Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial","Wang JB, Wang ZX, Jing J, Zhao P, Dong JH, Zhou YF, Yang G, Niu M, Zhao X, Jiang TJ, Bi JF, Xu Z, Zhang P, Wu D, Bai ZF, Guo YM, Yu SM, Sun YQ, Zhang ZT, Zhan XY, Li PY, Ding JB, Zhao PF, Song XA, Tang JY, He DC, Chen Z, Qin EQ, Wang RL, Xiao XH.","Chin J Integr Med. 2020 Sep;26(9):648-655. doi: 10.1007/s11655-020-3426-7. Epub 2020 Jul 16.","Wang JB","Chin J Integr Med","2020","2020/07/18","PMC7364292","","10.1007/s11655-020-3426-7"
"32673060","Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial","Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR.","Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16.","Skipper CP","Ann Intern Med","2020","2020/07/17","PMC7384270","","10.7326/M20-4207"
"32665394","Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer","Lakin JR, Brannen EN, Tulsky JA, Paasche-Orlow MK, Lindvall C, Chang Y, Gundersen DA, El-Jawahri A, Volandes A; ACP-PEACE Investigators.","BMJ Open. 2020 Jul 14;10(7):e040999. doi: 10.1136/bmjopen-2020-040999.","Lakin JR","BMJ Open","2020","2020/07/16","PMC7365491","","10.1136/bmjopen-2020-040999"
"32665041","Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial","Lai KSP, Watt C, Ionson E, Baruss I, Forchuk C, Sukhera J, Burhan AM, Vasudev A.","Trials. 2020 Jul 14;21(1):648. doi: 10.1186/s13063-020-04583-w.","Lai KSP","Trials","2020","2020/07/16","PMC7359429","","10.1186/s13063-020-04583-w"
"32661006","A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19","Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS.","Antimicrob Agents Chemother. 2020 Aug 20;64(9):e01061-20. doi: 10.1128/AAC.01061-20. Print 2020 Aug 20.","Davoudi-Monfared E","Antimicrob Agents Chemother","2020","2020/07/15","PMC7449227","","10.1128/AAC.01061-20"
"32641343","Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial","Liu F, Zhu Y, Zhang J, Li Y, Peng Z.","BMJ Open. 2020 Jul 8;10(7):e039519. doi: 10.1136/bmjopen-2020-039519.","Liu F","BMJ Open","2020","2020/07/10","PMC7348463","","10.1136/bmjopen-2020-039519"
"32641226","Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial","Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, DeVore AD, Gorodeski EZ, Desvigne-Nickens P, Hernandez AF, Braunwald E; LIFE Investigators.","JACC Heart Fail. 2020 Oct;8(10):789-799. doi: 10.1016/j.jchf.2020.05.005. Epub 2020 Jun 10.","Mann DL","JACC Heart Fail","2020","2020/07/10","PMC7286640","","10.1016/j.jchf.2020.05.005"
"32641154","Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial","Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB.","Trials. 2020 Jul 8;21(1):626. doi: 10.1186/s13063-020-04535-4.","Kulkarni S","Trials","2020","2020/07/10","PMC7341462","","10.1186/s13063-020-04535-4"
"32586399","Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial","Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I.","Trials. 2020 Jun 26;21(1):573. doi: 10.1186/s13063-020-04474-0.","Pantos C","Trials","2020","2020/06/27","PMC7316579","","10.1186/s13063-020-04474-0"
"32586396","CytoResc - ""CytoSorb"" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial","Stockmann H, Keller T, Büttner S, Jörres A, Kindgen-Milles D, Kunz JV, Leebmann J, Spies C, Träger K, Treskatsch S, Uhrig A, Willam C, Enghard P, Slowinski T; CytoResc Trial Investigators.","Trials. 2020 Jun 26;21(1):577. doi: 10.1186/s13063-020-04501-0.","Stockmann H","Trials","2020","2020/06/27","PMC7316574","","10.1186/s13063-020-04501-0"
"32586363","Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial","Allahyari A, Rahimi H, Khadem-Rezaiyan M, Mozaheb Z, Seddigh-Shamsi M, Bary A, Kamandi M, Azimi SA, HasanAbadi SE, Noferesti A, Shariatmaghani SS, Rafatpanah H, Khatami S, Imani AJ, Mortazi H, Nodeh MM.","Trials. 2020 Jun 26;21(1):575. doi: 10.1186/s13063-020-04485-x.","Allahyari A","Trials","2020","2020/06/27","PMC7316578","","10.1186/s13063-020-04485-x"
"32579195","Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial","Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators.","JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136.","Deftereos SG","JAMA Netw Open","2020","2020/06/25","PMC7315286","","10.1001/jamanetworkopen.2020.13136"
"32571773","Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018","Coenen S, van der Velden AW, Cianci D, Goossens H, Bongard E, Saville BR, Gobat N, de Paor M, Ieven M, Verheij TJ, Butler CC.","Br J Gen Pract. 2020 Jun 25;70(696):e444-e449. doi: 10.3399/bjgp20X711941. Print 2020 Jul.","Coenen S","Br J Gen Pract","2020","2020/06/24","PMC7311109","","10.3399/bjgp20X711941"
"32560744","AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial","Griffiths G, Fitzgerald R, Jaki T, Corkhill A, Marwood E, Reynolds H, Stanton L, Ewings S, Condie S, Wrixon E, Norton A, Radford M, Yeats S, Robertson J, Darby-Dowman R, Walker L, Khoo S; UK NIHR community.","Trials. 2020 Jun 19;21(1):544. doi: 10.1186/s13063-020-04473-1.","Griffiths G","Trials","2020","2020/06/21","PMC7303573","","10.1186/s13063-020-04473-1"
"32544867","Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial","Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P.","Int Immunopharmacol. 2020 Aug;85:106688. doi: 10.1016/j.intimp.2020.106688. Epub 2020 Jun 7.","Dastan F","Int Immunopharmacol","2020","2020/06/17","PMC7275997","","10.1016/j.intimp.2020.106688"
"32532356","Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)","Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y.","Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.","Ye Q","Trials","2020","2020/06/14","PMC7290137","","10.1186/s13063-020-04380-5"
"32521358","Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients","Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J; Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team; SPIN Investigators.","J Psychosom Res. 2020 Aug;135:110132. doi: 10.1016/j.jpsychores.2020.110132. Epub 2020 May 14.","Thombs BD","J Psychosom Res","2020","2020/06/11","PMC7224675","","10.1016/j.jpsychores.2020.110132"
"32492354","Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19","Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH.","Ann Am Thorac Soc. 2020 Sep;17(9):1144-1153. doi: 10.1513/AnnalsATS.202005-478SD.","Casey JD","Ann Am Thorac Soc","2020","2020/06/04","PMC7462324","","10.1513/AnnalsATS.202005-478SD"
"32492293","A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH.","N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.","Boulware DR","N Engl J Med","2020","2020/06/04","PMC7289276","","10.1056/NEJMoa2016638"
"32492084","Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial","Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z.","JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.","Li L","JAMA","2020","2020/06/04","PMC7270883","","10.1001/jama.2020.10044"
"32470486","Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial","Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, Zhou X, Luo H, Mao Z, Chen X, Xie J, Liu J, Cheng H, Zhao J, Huang G, Wang W, Zhou J.","J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3. doi: 10.1016/j.jaci.2020.05.019. Epub 2020 May 26.","Cao Y","J Allergy Clin Immunol","2020","2020/05/30","PMC7250105","","10.1016/j.jaci.2020.05.019"
"32461554","Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial","Demidowich AP, Levine JA, Apps R, Cheung FK, Chen J, Fantoni G; CHI Consortium, Patel TP, Yanovski JA.","Int J Obes (Lond). 2020 Aug;44(8):1793-1799. doi: 10.1038/s41366-020-0598-3. Epub 2020 May 27.","Demidowich AP","Int J Obes (Lond)","2020","2020/05/29","PMC7253147","","10.1038/s41366-020-0598-3"
"32450106","Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W.","Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.","Zhu FC","Lancet","2020","2020/05/26","PMC7255193","","10.1016/S0140-6736(20)31208-3"
"32423584","Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C.","Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.","Wang Y","Lancet","2020","2020/05/20","PMC7190303","","10.1016/S0140-6736(20)31022-9"
"32409561","Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, Wu Y, Xiao W, Liu S, Chen E, Chen W, Wang X, Yang J, Lin J, Zhao Q, Yan Y, Xie Z, Li D, Yang Y, Liu L, Qu J, Ning G, Shi G, Xie Q.","BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.","Tang W","BMJ","2020","2020/05/16","PMC7221473","","10.1136/bmj.m1849"
"32401715","Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY.","Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.","Hung IF","Lancet","2020","2020/05/14","PMC7211500","","10.1016/S0140-6736(20)31042-4"
"32383125","Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial","Lother SA, Abassi M, Agostinis A, Bangdiwala AS, Cheng MP, Drobot G, Engen N, Hullsiek KH, Kelly LE, Lee TC, Lofgren SM, MacKenzie LJ, Marten N, McDonald EG, Okafor EC, Pastick KA, Pullen MF, Rajasingham R, Schwartz I, Skipper CP, Turgeon AF, Zarychanski R, Boulware DR.","Can J Anaesth. 2020 Sep;67(9):1201-1211. doi: 10.1007/s12630-020-01684-7. Epub 2020 May 7.","Lother SA","Can J Anaesth","2020","2020/05/09","PMC7205369","","10.1007/s12630-020-01684-7"
"32330277","Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial","Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourão MPG, Brito-Sousa JD, Baía-da-Silva D, Guerra MVF, Hajjar LA, Pinto RC, Balieiro AAS, Pacheco AGF, Santos JDO Jr, Naveca FG, Xavier MS, Siqueira AM, Schwarzbold A, Croda J, Nogueira ML, Romero GAS, Bassat Q, Fontes CJ, Albuquerque BC, Daniel-Ribeiro CT, Monteiro WM, Lacerda MVG; CloroCovid-19 Team.","JAMA Netw Open. 2020 Apr 24;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857.","Borba MGS","JAMA Netw Open","2020","2020/04/25","","","10.1001/jamanetworkopen.2020.8857"
"32325038","Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C, Halwe S, Jeong Y, Park YS, Kim JO, Song M, Boyd A, Tran N, Silman D, Poulton I, Datoo M, Marshall J, Themistocleous Y, Lawrie A, Roberts R, Berrie E, Becker S, Lambe T, Hill A, Ewer K, Gilbert S.","Lancet Infect Dis. 2020 Jul;20(7):816-826. doi: 10.1016/S1473-3099(20)30160-2. Epub 2020 Apr 21.","Folegatti PM","Lancet Infect Dis","2020","2020/04/24","PMC7172901","","10.1016/S1473-3099(20)30160-2"
"32325037","Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM.","Lancet Infect Dis. 2020 Jul;20(7):827-838. doi: 10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21.","Koch T","Lancet Infect Dis","2020","2020/04/24","PMC7172913","","10.1016/S1473-3099(20)30248-6"
"32312018","Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19): Study Protocol Clinical Trial (SPIRIT Compliant)","Huang Z, Zhao S, Xu L, Chen J, Lin W, Zeng H, Chen Z, Du L, Shi Y, Zhang N, Song B.","Medicine (Baltimore). 2020 Apr;99(16):e19900. doi: 10.1097/MD.0000000000019900.","Huang Z","Medicine (Baltimore)","2020","2020/04/22","PMC7220219","","10.1097/MD.0000000000019900"
"32205204","Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D.","Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.","Gautret P","Int J Antimicrob Agents","2020","2020/03/25","PMC7102549","","10.1016/j.ijantimicag.2020.105949"
"32200994","High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial","Wu CN, Xia LZ, Li KH, Ma WH, Yu DN, Qu B, Li BX, Cao Y.","Br J Anaesth. 2020 Jul;125(1):e166-e168. doi: 10.1016/j.bja.2020.02.020. Epub 2020 Mar 20.","Wu CN","Br J Anaesth","2020","2020/03/24","PMC7269901","","10.1016/j.bja.2020.02.020"
"32187464","A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C.","N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.","Cao B","N Engl J Med","2020","2020/03/19","PMC7121492","","10.1056/NEJMoa2001282"
"31351922","Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Oh MD, Lamarre C, Zaidi FI, Boyer J, Kudchodkar SB, Jeong M, Darden JM, Park YK, Scott PT, Remigio C, Parikh AP, Wise MC, Patel A, Duperret EK, Kim KY, Choi H, White S, Bagarazzi M, May JM, Kane D, Lee H, Kobinger G, Michael NL, Weiner DB, Thomas SJ, Maslow JN.","Lancet Infect Dis. 2019 Sep;19(9):1013-1022. doi: 10.1016/S1473-3099(19)30266-X. Epub 2019 Jul 24.","Modjarrad K","Lancet Infect Dis","2019","2019/07/29","PMC7185789","","10.1016/S1473-3099(19)30266-X"
"28088167","Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections","Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA, Salata RA.","BMC Infect Dis. 2017 Jan 14;17(1):74. doi: 10.1186/s12879-016-2177-8.","Mukherjee PK","BMC Infect Dis","2017","2017/01/16","PMC5237564","","10.1186/s12879-016-2177-8"
"25922328","A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims","Wang M, Barasheed O, Rashid H, Booy R, El Bashir H, Haworth E, Ridda I, Holmes EC, Dwyer DE, Nguyen-Van-Tam J, Memish ZA, Heron L.","J Epidemiol Glob Health. 2015 Jun;5(2):181-9. doi: 10.1016/j.jegh.2014.08.002. Epub 2014 Oct 2.","Wang M","J Epidemiol Glob Health","2015","2015/04/30","PMC7103985","","10.1016/j.jegh.2014.08.002"
"24074841","A double-blind block randomized clinical trial on the effect of zinc as a treatment for diarrhea in neonatal Holstein calves under natural challenge conditions","Glover AD, Puschner B, Rossow HA, Lehenbauer TW, Champagne JD, Blanchard PC, Aly SS.","Prev Vet Med. 2013 Nov 1;112(3-4):338-47. doi: 10.1016/j.prevetmed.2013.09.001. Epub 2013 Sep 12.","Glover AD","Prev Vet Med","2013","2013/10/01","PMC7114245","","10.1016/j.prevetmed.2013.09.001"
"22712831","Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial","Howard PF, McCaw JM, Richmond PC, Nissen M, Sloots T, Lambert SB, Lai M, Greenberg M, Nolan T, McVernon J.","Influenza Other Respir Viruses. 2013 May;7(3):330-9. doi: 10.1111/j.1750-2659.2012.00395.x. Epub 2012 Jun 19.","Howard PF","Influenza Other Respir Viruses","2013","2012/06/21","PMC5779839","","10.1111/j.1750-2659.2012.00395.x"
"18824060","A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial","Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, Graham BS; VRC 301 Study Team.","Vaccine. 2008 Nov 25;26(50):6338-43. doi: 10.1016/j.vaccine.2008.09.026. Epub 2008 Sep 26.","Martin JE","Vaccine","2008","2008/10/01","PMC2612543","NIHMS83081","10.1016/j.vaccine.2008.09.026"
"18018769","Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","Lin JT, Zhang JS, Su N, Xu JG, Wang N, Chen JT, Chen X, Liu YX, Gao H, Jia YP, Liu Y, Sun RH, Wang X, Yu DZ, Hai R, Gao Q, Ning Y, Wang HX, Li MC, Kan B, Dong GM, An Q, Wang YQ, Han J, Qin C, Yin WD, Dongs XP.","Antivir Ther. 2007;12(7):1107-13.","Lin JT","Antivir Ther","2007","2007/11/21","","",""
"16261200","[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections]","Yu DX, Chen Q, Zhang LL, Liu Y, Yu ZA, Li ZF, Zhang LP, Hu GF, Duan ZJ, Chu XW, Zhang B, Yu SY, Hou YD.","Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep;19(3):216-9.","Yu DX","Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi","2005","2005/11/02","","",""
"16261199","[A field trial for evaluating the safety of recombinant human interferon alpha-2b for nasal spray]","Chen Q, Zhang LL, Yu DX, Yu ZA, Liu Y, Zhang LP, Li ZF, Duan ZJ, Wang BH, Wei XJ, Hu GF, Liu YQ, Chu XW, Han YH, Wu M, Jiang XL, Li JD, Dai YC, Nie J, Long J, Zhu L, Sun SX, Rui YY, Zhang DK, Yu SY, Hou YD.","Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep;19(3):211-5.","Chen Q","Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi","2005","2005/11/02","","",""
"2985213","A field trial to evaluate the efficacy of a combined rotavirus-coronavirus/Escherichia coli vaccine in dairy cattle","Waltner-Toews D, Martin SW, Meek AH, McMillan I, Crouch CF.","Can J Comp Med. 1985 Jan;49(1):1-9.","Waltner-Toews D","Can J Comp Med","1985","1985/01/01","PMC1236108","",""
